Top Tech Companies (721)
Don't see your company?
Create a company profile
Accord Healthcare is a large-scale provider of generic pharmaceuticals in the United States. Our U.S. headquarters is in Durham, North Carolina, near the Research Triangle Park (RTP). Situated in a 7,000-acre pine forest, RTP is one of the largest research parks in the world. Close to three major research universities, the area provides an unparalleled scientific, regulatory, quality, and commercial talent pool. Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976. Selling in over 75 countries, Accord has a vast global presence. The Accord and Intas networks provide full integration in the functional areas vital to delivering quality excellence and service efficiencies: API and finished dosage form manufacturing, R & D, clinical program management, and the economies of scale inherent in worldwide distribution. Accord is routinely cited in IQVIA presentations to industry as one of the fastest growing pharmaceutical companies in the U.S. Quarter-over-quarter, we consistently accomplish double-digit growth across all the metrics: in dollar sales, scripts filled, and number of units sold. We have accomplished this while undergoing multiple plant expansions across all of our manufacturing sites. Our solid record of maintaining high quality standards while implementing strategic commercial expansion has set us apart in the industry. Accord’s product offerings and pipeline demonstrate our commitment to meeting the needs of healthcare professionals and patients alike. We currently have approval for more than 115 ANDAs and are selling over 290 dosing presentations. We have 52 ANDAs pending at the FDA, and over 115 products in active development. Our pipeline spans a full range of dosage forms: orals, topicals, transdermal patches, liquid, lyophilized and complex injectables.
Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer.
BRC is a pharmaceutical manufacturing and development firm focused on the production of DEA approved cannabinoid API and botanically derived therapeutics. Our mission is to provide federally compliant, active pharmaceutical ingredients and plant-based therapeutics, with uncompromising quality, for patients and researchers everywhere.
Accentia Biopharmaceuticals discovers, develops and commercializes immunotherapies to treat autoimmune-related diseases and cancer.
Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities
Nobelpharma develops medicines and medical devices with a focus on underserved patient populations and undertreated medical conditions. Visit our website at https://www.nobelpharma-us.com
Turning Point Therapeutics is a structure-based drug design pharmaceutical company.
Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.
We are Soterius – a strong team of experienced professionals from the pharma industry. We design customized, innovative, and cost-efficient processes for clinical safety, pharmacovigilance, and medical affairs. Our deep industry knowledge and up to date insights let us combine agile, people powered intelligence with big data in pioneering customer centric solutions. Find us at www.soterius.com. #wearesoterius
Innox Digital is focused on developing augmented reality mobile applications for pharmaceutical products.
.jpeg)
.png)
Capsule is rebuilding the $425 billion pharmacy industry from the inside out with an emotionally resonant brand and technology that enables customized outcomes for doctors, hospitals, insurers, and manufacturers. Our team makes the same promise to each other as the one we’ve made to our customers, doctors, and partners: everybody needs some looking after sometimes. We’ll never lose sight of the fact that behind all the craziness of the healthcare system, we’re just people looking after other people. Capsule has raised over $500MM from the best healthcare and technology investors in the world.
About Enzyvant Enzyvant is a biopharmaceutical company making life-altering impact for people affected by rare disease, where communities are small, and the human need is immense. Enzyvant partners with these communities to accelerate development of transformative medicines, collaborating with academia, industry, physician associations, advocacy groups and government, because strong relationships make bold science possible. Enzyvant has capabilities spanning non-clinical and clinical development and commercialization and is developing in-house manufacturing. The company delivered one of the first Regenerative Medicine Advanced Therapy products and makes promising advances against some of the greatest challenges in immunology and cardiopulmonology. For more information about Enzyvant, visit www.Enzyvant.com.
BioSymetrics is an AI-powered drug discovery company.
Sinapis Pharma is a clinical stage biotechnology company that has identified a new use and route of administration for methamphetamine.
.jpg)
ENCO Pharmaceutical Development, Inc (EPDI) provides comprehensive product development services to the pharmaceutical and medical device market. From its locations in Jacksonville FL and Cary NC, we provide customers around the world with high quality analytical services, comprehensive stability storage and related testing, as well as a full complement of product and formulation development services.
Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world. We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potential for new innovation. We build on remarkable foundations and a legacy of providing reliable and consistent nuclear solutions to tens of thousands of patients every day. Our proven heritage combined with a pioneering approach are the hallmarks from which we provide life-changing diagnostics and therapeutics. Our people are the root of the incredible impact they have. As part of our 2030 vision to become an oncology-focused nuclear medicine leader – both in diagnostics and therapy – we will expand our reach further into Japan and China, continuing to roll out our superior products to a global market. The impact of these investments on patients will be life changing. Our cancer focus is currently in Neuroendocrine Tumors (NETs) and prostate cancer PSMA. We are also working on leveraging the power of AI to improve image quality and accuracy; to identify patterns to help diagnose pathologies and of course to better support physicians. Our Promise We strive to make the impossible possible and to be an organization that will change the face of medicine. Our diverse group of industry experts is unified under one strong and singular focus – to develop, manufacture and supply revolutionary diagnostic and therapeutic radiopharmaceuticals to our customers around the globe with unrivaled reliability and superior service.
Arbor Pharmaceuticals is a specialty pharmaceutical company developing late-stage therapeutic products for common pediatric conditions.
Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at its dedicated research center in Omaha, NE, and conducts Phase 1-4 studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. Meridian offers: - Rapid data turnaround, easy communication, and fast start-up. - Broad therapeutic expertise and support for special patient populations. - Call centers to expedite patient recruitment, retention, and follow-up. - Access to an expansive site network and patient database (Platinum Research Network member). Meridian maintains proprietary patient databases and leverages research and physician practice databases to provide direct access to potential study participants. Meridian is also the largest member of the Platinum Research Network, which provides access to more than 47 million patients globally. Due to the strategic footprint of this site network, Meridian studies often serve as an additional care option for patients currently seeking treatment for conditions. Geographically and demographically diverse, Meridian’s network enables prompt access to a viable study infrastructure.
NuSirt is focused on the development of novel drugs for the treatment of diabetes and other metabolic disorders including obesity, arteriosclerosis, and hyperlipidemia.
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
